| Bioactivity: | β-Amyloid (1-42) is widely recognized as the most pathogenic isoform of the amyloid beta peptide and a primary constituent of senile plaques in the brains of Alzheimer's disease patients. The two additional C-terminal hydrophobic residues (isoleucine and leucine) compared to Aβ1-40 confer a markedly higher propensity for self-aggregation, beta-sheet formation, and oligomerization — properties directly implicated in neuronal dysfunction and apoptosis. This peptide is extensively employed in studies of amyloid nucleation-dependent polymerization, protofibril and oligomer characterization, metal ion coordination chemistry, and as an immunogen for generating conformation-specific antibodies. It is also utilized in high-throughput drug screening platforms designed to identify small-molecule inhibitors of amyloid assembly and in cell-based neurotoxicity models including SH-SY5Y, PC12, and primary hippocampal neuronal cultures. |
|---|---|
| Three-letter Sequence: | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile- Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
| Appearance: | White lyophilized powder |
| Counter Ion: | Trifluoroacetate (TFA) |
| Storage: | Power: -20°C(1 year) or -80°C(1~2 years) ; In solvent: -20°C(1 month) or -80°C(5~6 months) |
| Reconstitution: | Acetic acid/water (3:2) or DMSO |
| Shipping: | All peptides will be shipped as lyophilized powder with desiccant at room temperature. |
Q:What is the usage method of this product?
A:Prevent the use of open flames, normal temperature is sufficient